210 related articles for article (PubMed ID: 22875710)
21. Targeting Glioma Initiating Cells with A combined therapy of cannabinoids and temozolomide.
López-Valero I; Saiz-Ladera C; Torres S; Hernández-Tiedra S; García-Taboada E; Rodríguez-Fornés F; Barba M; Dávila D; Salvador-Tormo N; Guzmán M; Sepúlveda JM; Sánchez-Gómez P; Lorente M; Velasco G
Biochem Pharmacol; 2018 Nov; 157():266-274. PubMed ID: 30195736
[TBL] [Abstract][Full Text] [Related]
22. Cannabinoid receptors, CB1 and CB2, as novel targets for inhibition of non-small cell lung cancer growth and metastasis.
Preet A; Qamri Z; Nasser MW; Prasad A; Shilo K; Zou X; Groopman JE; Ganju RK
Cancer Prev Res (Phila); 2011 Jan; 4(1):65-75. PubMed ID: 21097714
[TBL] [Abstract][Full Text] [Related]
23. Cannabinoid CB1 and CB2 receptor ligand specificity and the development of CB2-selective agonists.
Ashton JC; Wright JL; McPartland JM; Tyndall JD
Curr Med Chem; 2008; 15(14):1428-43. PubMed ID: 18537620
[TBL] [Abstract][Full Text] [Related]
24. Cannabinoid Signaling in Glioma Cells.
Ellert-Miklaszewska A; Ciechomska IA; Kaminska B
Adv Exp Med Biol; 2020; 1202():223-241. PubMed ID: 32034716
[TBL] [Abstract][Full Text] [Related]
25. Antitumor activity of novel pyrazole-based small molecular inhibitors of the STAT3 pathway in patient derived high grade glioma cells.
Zhang L; Peterson TE; Lu VM; Parney IF; Daniels DJ
PLoS One; 2019; 14(7):e0220569. PubMed ID: 31361777
[TBL] [Abstract][Full Text] [Related]
26. Targeting autophagy enhances BO-1051-induced apoptosis in human malignant glioma cells.
Chu PM; Chen LH; Chen MT; Ma HI; Su TL; Hsieh PC; Chien CS; Jiang BH; Chen YC; Lin YH; Shih YH; Tu PH; Chiou SH
Cancer Chemother Pharmacol; 2012 Mar; 69(3):621-33. PubMed ID: 21947203
[TBL] [Abstract][Full Text] [Related]
27. Receptor mechanism and antiemetic activity of structurally-diverse cannabinoids against radiation-induced emesis in the least shrew.
Darmani NA; Janoyan JJ; Crim J; Ramirez J
Eur J Pharmacol; 2007 Jun; 563(1-3):187-96. PubMed ID: 17362921
[TBL] [Abstract][Full Text] [Related]
28. Hypothesis: cannabinoid therapy for the treatment of gliomas?
Velasco G; Galve-Roperh I; Sánchez C; Blázquez C; Guzmán M
Neuropharmacology; 2004 Sep; 47(3):315-23. PubMed ID: 15275820
[TBL] [Abstract][Full Text] [Related]
29. Activation of cannabinoid type 2 receptor by JWH133 protects heart against ischemia/reperfusion-induced apoptosis.
Li Q; Wang F; Zhang YM; Zhou JJ; Zhang Y
Cell Physiol Biochem; 2013; 31(4-5):693-702. PubMed ID: 23711495
[TBL] [Abstract][Full Text] [Related]
30. Oxaliplatin disrupts pathological features of glioma cells and associated macrophages independent of apoptosis induction.
Roberts NB; Alqazzaz A; Hwang JR; Qi X; Keegan AD; Kim AJ; Winkles JA; Woodworth GF
J Neurooncol; 2018 Dec; 140(3):497-507. PubMed ID: 30132163
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic potential of a novel cannabinoid agent CB52 in the mouse model of experimental autoimmune encephalomyelitis.
Ribeiro R; Yu F; Wen J; Vana A; Zhang Y
Neuroscience; 2013 Dec; 254():427-42. PubMed ID: 24036373
[TBL] [Abstract][Full Text] [Related]
32. PEGylated Polyamidoamine dendrimer conjugated with tumor homing peptide as a potential targeted delivery system for glioma.
Jiang Y; Lv L; Shi H; Hua Y; Lv W; Wang X; Xin H; Xu Q
Colloids Surf B Biointerfaces; 2016 Nov; 147():242-249. PubMed ID: 27518456
[TBL] [Abstract][Full Text] [Related]
33. Opposite changes in cannabinoid CB1 and CB2 receptor expression in human gliomas.
De Jesús ML; Hostalot C; Garibi JM; Sallés J; Meana JJ; Callado LF
Neurochem Int; 2010; 56(6-7):829-33. PubMed ID: 20307616
[TBL] [Abstract][Full Text] [Related]
34. Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells.
Salazar M; Carracedo A; Salanueva IJ; Hernández-Tiedra S; Lorente M; Egia A; Vázquez P; Blázquez C; Torres S; García S; Nowak J; Fimia GM; Piacentini M; Cecconi F; Pandolfi PP; González-Feria L; Iovanna JL; Guzmán M; Boya P; Velasco G
J Clin Invest; 2009 May; 119(5):1359-72. PubMed ID: 19425170
[TBL] [Abstract][Full Text] [Related]
35. Capillary morphogenesis protein 2 is a novel prognostic biomarker and plays oncogenic roles in glioma.
Tan J; Liu M; Zhang JY; Yao YL; Wang YX; Lin Y; Song K; Tan J; Wu JR; Cui YH; Wang Y; Bian XW
J Pathol; 2018 Jun; 245(2):160-171. PubMed ID: 29473166
[TBL] [Abstract][Full Text] [Related]
36. Cannabinoid CB
Olianas MC; Dedoni S; Onali P
Life Sci; 2021 Jul; 276():119407. PubMed ID: 33794254
[TBL] [Abstract][Full Text] [Related]
37. Anti-tumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation.
Galve-Roperh I; Sánchez C; Cortés ML; Gómez del Pulgar T; Izquierdo M; Guzmán M
Nat Med; 2000 Mar; 6(3):313-9. PubMed ID: 10700234
[TBL] [Abstract][Full Text] [Related]
38. The effects of cannabinoids on glioblastoma growth: A systematic review with meta-analysis of animal model studies.
Luís Â; Marcelino H; Rosa C; Domingues F; Pereira L; Cascalheira JF
Eur J Pharmacol; 2020 Jun; 876():173055. PubMed ID: 32145324
[TBL] [Abstract][Full Text] [Related]
39. Repurposing FDA approved drugs inhibiting mitochondrial function for targeting glioma-stem like cells.
Datta S; Sears T; Cortopassi G; Woolard K; Angelastro JM
Biomed Pharmacother; 2021 Jan; 133():111058. PubMed ID: 33378970
[TBL] [Abstract][Full Text] [Related]
40. Phospho-valproic acid (MDC-1112) suppresses glioblastoma growth in preclinical models through the inhibition of STAT3 phosphorylation.
Luo D; Fraga-Lauhirat M; Millings J; Ho C; Villarreal EM; Fletchinger TC; Bonfiglio JV; Mata L; Nemesure MD; Bartels LE; Wang R; Rigas B; Mackenzie GG
Carcinogenesis; 2019 Dec; 40(12):1480-1491. PubMed ID: 30994173
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]